drugset / Trial / NCT00567099
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is the use of magnetoencephalography or MEG (a machine that measures magnetic activity in your brain) and electroencephalography or EEG (a technique that measures electrical activity in your brain) to study how sounds are processed in individuals with schizophrenia prior to initiation with aripiprazole treatment and after three months of taking the antipsychotic medication aripiprazole.
Timeline
- Start
- 2003-08
- Primary completion
- —
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 5 mg | Oral |
| Subject | Aripiprazole | Other / unclassified | 30 mg | Oral |